[HTML][HTML] Irritable bowel syndrome: relations with functional, mental, and somatoform disorders

C Hausteiner-Wiehle, P Henningsen - World journal of …, 2014 - ncbi.nlm.nih.gov
This review describes the conceptual and clinical relations between irritable bowel
syndrome (IBS), other functional, somatoform, and mental disorders, and points to …

Efficacy, tolerability, and safety of hypnosis in adult irritable bowel syndrome: systematic review and meta-analysis

R Schaefert, P Klose, G Moser… - Psychosomatic medicine, 2014 - journals.lww.com
Objective To assess the efficacy, tolerability, and safety of hypnosis in adult irritable bowel
syndrome by a meta-analysis of randomized controlled trials. Methods Studies were …

British Dietetic Association systematic review of systematic reviews and evidence‐based practice guidelines for the use of probiotics in the management of irritable …

YA McKenzie, J Thompson, P Gulia… - Journal of Human …, 2016 - Wiley Online Library
Background Probiotics are often taken by individuals with irritable bowel syndrome (IBS).
Which products are effective is unclear, despite an increasing research base. This project …

Incidence of irritable bowel syndrome and chronic fatigue following GI infection: a population-level study using routinely collected claims data

E Donnachie, A Schneider, M Mehring, P Enck - Gut, 2018 - gut.bmj.com
Objectives To investigate the occurrence of postinfectious IBS in routine outpatient care,
comparing different types of GI infection and its interaction with psychosomatic comorbidity …

[HTML][HTML] The prevalence, comorbidity, management and costs of irritable bowel syndrome: an observational study using routine health insurance data

W Häuser, U Marschall, P Layer… - Deutsches Ärzteblatt …, 2019 - ncbi.nlm.nih.gov
Background Insufficient data are available on the administrative incidence and prevalence
of irritable bowel syndrome (IBS) in Germany, as well as on its comorbidities, diagnostic …

Linaclotide for the management of irritable bowel syndrome with constipation

P Layer, V Stanghellini - Alimentary pharmacology & …, 2014 - Wiley Online Library
Background Irritable bowel syndrome with constipation (IBS‐C) represents a significant
burden to patients and healthcare systems due to its prevalence and lack of successful …

Effects of an oral synbiotic on the gastrointestinal immune system and microbiota in patients with diarrhea-predominant irritable bowel syndrome

AM Moser, W Spindelboeck, B Halwachs… - European journal of …, 2019 - Springer
Purpose Diarrhea-predominant irritable bowel syndrome (IBS-D) is a common functional
gastrointestinal disorder. Probiotics and synbiotics have been shown to improve symptoms …

[HTML][HTML] Functional bowel disorders in adults

W Häuser, P Layer, P Henningsen… - Deutsches Ärzteblatt …, 2012 - ncbi.nlm.nih.gov
Background Chronic abdominal pain, bloating, constipation, diarrhea, and stool irregularity
are common symptoms in primary care and gastroenterology. A routine diagnostic …

Evaluating the multitarget effects of combinations through multistep clustering of pharmacological data: the example of the commercial preparation Iberogast

H Abdel-Aziz, O Kelber, G Lorkowski, M Storr - Planta medica, 2017 - thieme-connect.com
Herbal combination preparations are widely used in traditional herbal medicine and are
even established as modern evidence-based herbal medicinal products. The rationale …

Potential causes and present pharmacotherapy of irritable bowel syndrome: an overview

T Bokic, M Storr, R Schicho - Pharmacology, 2015 - karger.com
Background: Irritable bowel syndrome (IBS) is currently one of the most common disorders
of the digestive system in the Western society. Almost 2 out of 10 people suffer from IBS with …